What is JBIO's cash ratio?

JBIO (JBIO) reported cash ratio of 2.5× in Q1 2026.

How has JBIO's cash ratio changed year-over-year?

JBIO's cash ratio decreased by 86.5% year-over-year, from 18.3× to 2.5×.

What is the long-term trend for JBIO's cash ratio?

Over 5 years (2020 to 2025), JBIO's cash ratio has grown at a 15.6% compound annual growth rate (CAGR), from 2.6× to 5.3×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

JBIO JBIO Cash ratio

Cash ratio at other companies

Vertex PharmaceuticalsVRTX

1.4×+0.2×

Travere Therapeutics, Inc.TVTX

0.6×+0.3×

Vera TherapeuticsVERA

2.5×0.0×

AnaptysBio, Inc.ANAB

6×+3.7×

Avalo TherapeuticsAVTX

2.2×-20.1×

Cullinan Therapeutics, Inc.CGEM

2.1×-0.7×

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Market cap$1.33B+318%

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Calculated from JBIO’s reported figures.

cash and equivalents/total current liabilities=2.5×

Based on the most recent quarter.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's cash ratio?: JBIO (JBIO) reported cash ratio of 2.5× in Q1 2026.
How has JBIO's cash ratio changed year-over-year?: JBIO's cash ratio decreased by 86.5% year-over-year, from 18.3× to 2.5×.
What is the long-term trend for JBIO's cash ratio?: Over 5 years (2020 to 2025), JBIO's cash ratio has grown at a 15.6% compound annual growth rate (CAGR), from 2.6× to 5.3×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.